The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 26, 2016
Filed:
Feb. 03, 2014
Shuwen He, Fanwood, NJ (US);
Xing Dai, Cranford, NJ (US);
Anandan Palani, Bridgewater, NJ (US);
Ravi Nargund, East Brunswick, NJ (US);
Zhong Lai, East Brunswick, NJ (US);
Nicolas Zorn, Durmenach, FR;
Dong Xiao, Warren, NJ (US);
Qun Dang, Westfield, NJ (US);
Casey C. Mccomas, Pheonixville, PA (US);
Peng LI, Shanghai, CN;
Xuanjia Peng, Shanghai, CN;
Richard Soll, Shanghai, CN;
Shuwen He, Fanwood, NJ (US);
Xing Dai, Cranford, NJ (US);
Anandan Palani, Bridgewater, NJ (US);
Ravi Nargund, East Brunswick, NJ (US);
Zhong Lai, East Brunswick, NJ (US);
Nicolas Zorn, Durmenach, FR;
Dong Xiao, Warren, NJ (US);
Qun Dang, Westfield, NJ (US);
Casey C. McComas, Pheonixville, PA (US);
Peng Li, Shanghai, CN;
Xuanjia Peng, Shanghai, CN;
Richard Soll, Shanghai, CN;
Merck Sharp & Dohme Corp., Rahway, NJ (US);
Abstract
The present invention relates to compounds of formula (I) that are useful as hepatitis C virus (HCV) NS5B polymerase inhibitors, the synthesis of such compounds, and the use of such compounds for inhibiting HCV NS5B polymerase activity, for treating or preventing HCV infections and for inhibiting HCV viral replication and/or viral production in a cell-based system.